The applicant intends to market cycloastragenol as a novel food ingredient to be incorporated into food supplements.
Cycloastragenol is obtained from Astragalus trojanus a perennial flowering shrub of the Fabaceae (or legume) family. Other species of Astragalus, most notably A. membranaceus, which also contain cycloastragenol are available in food supplements in the EU. Cycloastragenol is the most common triterpede aglycone (often referred to as astragalosides) found in Astragalus sp. Triterpede aglycones belong to a class of secondary plant metabolites known as saponins.
The applicant states that the product is to be used for the maintenance or enhancement of physiological functions in the body that are associated with wellbeing and health.
Before any new food product can be introduced on the European market, it must be rigorously assessed for safety. In the UK, the assessment of novel foods is carried out by an independent committee of scientists appointed by the Food Standards Agency, the Advisory Committee on Novel Foods and Processes (ACNFP).
Any comments on this application dossier should be sent to the ACNFP Secretariat by 31 March 2014. Comments will be taken into account by the Committee before it adopts its final opinion on this ingredient.
All views/comments received by the Agency will be made available for public examination. If you would prefer your comments NOT to be made publicly available, please indicate this by fully completing and returning the data protection form (attached below) together with your response.